Gestational Diabetes Mellitus is increasing in incidence all over the world, more rapidly than any other type of diabetes. Currently, up to 12% of pregnancies in Australia are affected by this condition.
GDM exposes both mothers and their babies to short and long term complications as obesity, diabetes later in life, cardiovascular diseases.
Improving the diagnosis of this condition would hence mean working at the current and future health of two people at a time.
Reducing the misdiagnosis of GDM could make a difference in the rates of the most growing deadly conditions worldwide.
We consider the current sugar test for GDM, the OGTT, to have many limits. We hence want to understand if Continuous Glucose Monitoring (CGM) can be used to check for Gestational Diabetes (GDM), and how pregnant women feel about CGM.
Our group already concluded a preliminary study
on over 70 women demonstrating great results
of the CGM in terms of reliability and
acceptability for women.
We now aim to confirm these results with another CGM device and to further study the CGM traces of women with and without GDM.
Continuous Glucose Monitoring is a simple-to-use device that allows evaluating the
Blood Glucose Levels during women's ordinary life.
In this pilot study, we will use the Abbott Freestyle Libre CGM, which we expect to be highly acceptable for women as it does not need to be worn on the belly neither to be calibrated with finger pricks.